Roche/Glaxo osteoporosis treatment approved in Switzerland
12th Sep 2005, 13:51 GMT
The Swiss authorities have approved Roche and GlaxoSmithKline's Bonviva for the treatment of postmenopausal osteoporosis, providing the foundations for approval in other countries.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol